Showing results (21-30 of 30) with videos related to
Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 30 results.
International Journal of Molecular Sciences|February 25, 2023
ProCPU Is Expressed by (Primary) Human Monocytes and Macrophages and Expression Differs between States of Differentiation and ActivationKaren Claesen, Joni De Loose, Pieter Van Wielendaele, et al.Clinical Therapeutics|April 29, 2021
Effect of Statin Therapy on the Carboxypeptidase U (CPU, TAFIa, CPB2) System in Patients With Hyperlipidemia: A Proof-of-concept Observational StudyKaren Claesen, Joachim C Mertens, Shahir Basir, et al.Arteriosclerosis, Thrombosis, and Vascular Biology|May 6, 2003
Development of a genotype 325-specific proCPU/TAFI ELISAAnn Gils, Marie-Christine Alessi, Els Brouwers, et al.The Journal of Histochemistry and Cytochemistry : Official Journal of the Histochemistry Society|November 23, 2012
Mapping of carboxypeptidase m in normal human kidney and renal cell carcinoma: expression in tumor-associated neovasculature and macrophagesCatherine J Denis, Nathalie Van Acker, Stefanie De Schepper, et al.The FEBS Journal|January 31, 2006
Limited mutagenesis increases the stability of human carboxypeptidase U (TAFIa) and demonstrates the importance of CPU stability over proCPU concentration in down-regulating fibrinolysisWolfgang Knecht, Johan Willemse, Hanna Stenhamre, et al.Journal of Thrombosis and Haemostasis : JTH|September 2, 2020
Selective inhibition of carboxypeptidase U may reduce microvascular thrombosis in rat experimental strokeJoachim C Mertens, William Boisseau, Dorien Leenaerts, et al.Journal of Thrombosis and Haemostasis : JTH|February 5, 2023
Atorvastatin downregulates plasma procarboxypeptidase U concentrations and improves fibrinolytic potential dose-dependently in hyperlipidemic individualsKaren Claesen, Yani Sim, Shahir Basir, et al.Journal of Thrombosis and Haemostasis : JTH|July 8, 2020
A new pedigree with thrombomodulin-associated coagulopathy in which delayed fibrinolysis is partially attenuated by co-inherited TAFI deficiencySarah K Westbury, Claire S Whyte, Jonathan Stephens, et al.Journal of Clinical Medicine|March 25, 2022
Activation of the Carboxypeptidase U (CPU, TAFIa, CPB2) System in Patients with SARS-CoV-2 Infection Could Contribute to COVID-19 Hypofibrinolytic State and Disease Severity PrognosisKaren Claesen, Yani Sim, An Bracke, et al.Clinica Chimica Acta; International Journal of Clinical Chemistry|March 14, 2022
Proline-specific peptidase activities (DPP4, PRCP, FAP and PREP) in plasma of hospitalized COVID-19 patientsAn Bracke, Emilie De Hert, Michelle De Bruyn, et al.Pageof 3